Skip to main content

Ikarian Capital, LLC

Position in FULC — Fulcrum Therapeutics, Inc.

CIK 1778253 DALLAS, TX

Position in FULC

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$8,047,064
-$7,509,524 QoQ
Shares Held
1,049,161
-23.7% QoQ
Ownership
1.57%
of shares outstanding
% of Portfolio
1.14%
of 13F equity value
Holder Rank
#23
of 168 holders
Holding Since
Dec 2020
11 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in FULC Over Time

Shares Held

Position Value (USD)

Derivatives in FULC

reported options exposure · as of Jun 30, 2025
CallValue
$3,673,920
CallShares
534,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Ikarian Capital, LLC holds $650,566,917 across 105 Biotechnology names. FULC ranks #28 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in FULC

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $8,047,064 1,049,161
2025-12-31 $15,556,588 1,375,472
2025-09-30 $11,860,870 1,289,225
2025-06-30 $3,673,920 534,000
2025-06-30 $2,948,224 428,521
2025-03-31 $576,276 200,096
2024-12-31 $940,451 200,096
2024-09-30 $81,396 22,800
2024-09-30 $267,750 75,000
2024-09-30 $1,509,396 422,800
2022-06-30 $892,780 182,200
2021-06-30 $1,705,096 162,700
2021-03-31 $5,026,985 426,739
2020-12-31 $5,125,467 437,700